Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy

dc.contributor.authorBannister, Aaron
dc.contributor.supervisorChithrani, Devika
dc.date.accessioned2019-12-10T23:42:10Z
dc.date.copyright2019en_US
dc.date.issued2019-12-10
dc.degree.departmentDepartment of Physics and Astronomyen_US
dc.degree.levelMaster of Science M.Sc.en_US
dc.description.abstractOBJECTIVE: One of the major issues in current radiotherapy (RT) is the normal tissue toxicity. A smart combination of agents within the tumor would allow lowering the RT dose required while minimizing the damage to healthy tissue surrounding the tumor. We chose gold nanoparticles (GNPs) and docetaxel (DTX) as our choice of two radiosensitizing agents. They have a different mechanism of action which could lead to synergistic effect. Our first goal was to assess the variation in GNP uptake, distribution, and retention in the presence of DTX. Our second goal was to assess the therapeutic results of the triple combination, RT/GNPs/DTX. METHODS: We used HeLa and MDA-MB-231 cells for our study. Cells were incubated with GNPs (0.2nM) in the absence and presence of DTX (50nM) for 24 hrs for determination of uptake, distribution, and retention of NPs. For RT experiment, treated cells were given a 2 Gy dose of 6 MV photons using a linear accelerator. RESULTS: Concurrent treatment of DTX and GNPs resulted in over 85% retention of GNPs in tumor cells. DTX treatment also forced GNPs to be closer to the most important target, the nucleus, resulting in a significant decrease in cell survival with the triple combination of RT, GNPs, and DTX vs. RT plus DTX alone. Our experimental therapeutics results are supported by Monte Carlo simulations. CONCLUSION: The ability to not only trap GNPs at clinically feasible doses but also to retain them within the cells could lead to meaningful fractionated treatments in future combined cancer therapy. Furthermore, the suggested triple combination of RT/GNPs/DTX may allow lowering the RT dose to spare surrounding healthy tissue. ADVANCES IN KNOWLEDGE: This is the first study to show intracellular GNP transport disruption by DTX, and its advantage in radiosensitization.en_US
dc.description.embargo2020-10-31
dc.description.scholarlevelGraduateen_US
dc.identifier.urihttp://hdl.handle.net/1828/11355
dc.languageEnglisheng
dc.language.isoenen_US
dc.rightsAvailable to the World Wide Weben_US
dc.subjectgold nanoparticleen_US
dc.subjectnanoparticleen_US
dc.subjectcanceren_US
dc.subjectdocetaxelen_US
dc.subjecttaxotereen_US
dc.subjectradiotherapyen_US
dc.subjectendocytosisen_US
dc.subjectexocytosisen_US
dc.subjectmicrotubuleen_US
dc.titleModulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapyen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bannister_Aaron_MSc_2019.pdf
Size:
3.34 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: